These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8420262)

  • 1. Use of glycyrrhizin for recurrence of hepatitis B after liver transplantation.
    Matsunami H; Lynch SV; Balderson GA; Strong RW
    Am J Gastroenterol; 1993 Jan; 88(1):152-3. PubMed ID: 8420262
    [No Abstract]   [Full Text] [Related]  

  • 2. A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure.
    Acharya SK; Dasarathy S; Tandon A; Joshi YK; Tandon BN
    Indian J Med Res; 1993 Apr; 98():69-74. PubMed ID: 8344734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine.
    Fujisawa K
    Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032
    [No Abstract]   [Full Text] [Related]  

  • 4. [A double-blind study of strong neominophagen-C in treating chronic hepatitis].
    Wang JT
    Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):14-8, 62. PubMed ID: 6396046
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of nonalcoholic steatohepatitis (NASH)].
    Nakashima T; Sumida Y; Mitsuyoshi H; Okanoue T
    Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1204-8. PubMed ID: 15570868
    [No Abstract]   [Full Text] [Related]  

  • 6. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
    Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P
    Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypersensitivity to glycyrrhizin. A case report.
    Kuriyama Y; Takano T; Okada F; Nukada T
    Med J Osaka Univ; 1975 Sep; 26(12):75-8. PubMed ID: 1228395
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alternative therapies for hepatitis C: UDCA and SNMC].
    Matsuzaki Y; Ikegami T; Saito Y
    Nihon Rinsho; 2011 May; 69 Suppl 4():256-61. PubMed ID: 22096928
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrence of HDV infection after liver transplantation.
    Bettale G; Alberti A; Belli LS; Rondinara G; De Carlis L; Vai C; Zavaglia C; Belli L; Ideo G
    Prog Clin Biol Res; 1993; 382():403-7. PubMed ID: 8502710
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention and treatment of hepatitis B relapse after liver transplantation.
    Zhu X; Lu M; Wang G; Cai C; Yang Y; He X; Chen G; Huang J
    Chin Med J (Engl); 2001 Jan; 114(1):73-5. PubMed ID: 11779441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Testino G; Borro P; Sumberaz A
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):139-41. PubMed ID: 19565040
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience of prophylaxis and treatment of hepatitis B recurrence in liver transplantation recipients].
    Wang HZ; Dong JH; Wang SG; Bie P; He Y; Lu Q
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):46, 48. PubMed ID: 14761286
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prophylaxsis against recurrance of hepatitis B virus after liver transplantation].
    Wu JS; Lu SC; Wang ML; Xia RP; Guo QL; Gao DM; Zhang Y; Liu Y; Li N
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):367-9. PubMed ID: 19469177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
    Wang ZF; Zhu ZJ; Shen ZY
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):509-14. PubMed ID: 16286253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of wild-type and precore mutant HBV infection after liver transplantation.
    Torre F; Wong PY; Macartney M; Williams R; Naoumov NV
    J Med Virol; 1999 Sep; 59(1):5-13. PubMed ID: 10440801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of the protection of SNMC in HepG2 cell apoptosis].
    Wang Y; Ma YJ; Yang BS; Bi MR; Chen LY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):132-5. PubMed ID: 15727703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hepatitis B virus recurrence after living donor liver transplantation.
    Ali H; Egawa H; Uryuhara K; Ogawa K; Kasahara M; Ueda M; Marusawa H; Nabeshima M; Tanaka K
    Transplant Proc; 2004 Nov; 36(9):2764-7. PubMed ID: 15621143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of hepatitis B in liver transplants treated with antiviral therapy.
    Marzano A; Debernardi-Venon W; Smedile A; Brunetto MR; Torrani Cerenzia MR; Actis GC; Zamboni F; Ghisetti V; Piantino P; David E; Salizzoni M; Rizzetto M
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):77-81. PubMed ID: 9615271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.